iXpressGenes, Inc.
Software that analyzes protein crystallization screening data using Associated Experimental Design (AED) approach to predict optimal crystallization conditions and generate targeted screening experime
- Sector
- Biotech
- Headquarters
- HUNTSVILLE, AL
- Latest Form D
- $2.4M, Jun 2025
- Total capital
- $5.2M
- Federal grants
- $2.3M
- 5 awards · 2015–2017
- Rank in peer group#15 of 19
- Private capital raised
- $2.4M
- 1 Form D · last Jun 2025
- 16 months since last filing
- Federal contracts
- $614K
- 5 awards · NASA, Veterans Affairs
- Rank in Biotech#215 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal contractVeterans Affairs · Research Lab Services And Specialized Blood Transcriptome Services$132K
- Private capital raisedForm D · SEC · 1st filing$2.4M
- Federal grantHealth and Human S · Phase II · Macromolecule Crystallization Screening Results Analysis$469K
- Federal grantDefense · Phase II · Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes$1.0M
- Federal grantHealth and Human S · Phase II · Macromolecule Crystallization Screening Results Analysis$490K
- Federal grantDefense · Phase I · Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes$144K
- Federal contractNASA · Igf::ot::igf The Purpose Of This Procurement Is To Acquire Services For The Maintenance And Use Of A Protein Crystal Growth Rate Measurement And Protein Crystal Solubility Apparatus. Scope Of Work (sow) For Services In The Measurement Of Protein Crystal Face Growth Rates And Apparatus Maintenance.$60K
Show 4 earlier federal awards
- Federal grantHealth and Human S · Phase I · Macromolecule Crystallization Screening Results Analysis$150K
- Federal contractNASA · Igf::ot::igf Scope Of Work (sow) For Services In The Measurement Of Protein Crystal Face Growth Rates And Apparatus Maintenance An Optical System Designed And Assembled To Measure The Face Growth Rates Of Protein Crystals Has Been Implemented In The Biological Physics Laboratory, Located In Bldg. 4602/RM. 1183. The System Has The Capacity To Determine Face Growth Rates Of Protein Crystals By Monitoring The Growth Of 1 To 20 Different Crystals During A Single Experiment, At A Defined Temperature$70K
- Federal contractNASA · Igf::cl::igf Develop And Implementation Of A Solubility Measurements Fluorescence Imaging Appartus$147K
- Federal contractNASA · Optical System To Measure Protien Crystals$205K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
144months
from iXpressGenes, Inc.’s first federal award to its first private round.
- First federal award · Jul 2013
- NASA · $205K
- First Form D · Jun 2025
- $2.4M · 1st Form D
- Awards before first raise
- 9 awards
An association in public records, not a cause or a prediction.
Standing among 19 peers
Line = medianBiotech · Software
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Barbara FiskDirectorNamed in SEC Form D filings
- John SchmittExecutive Officer, DirectorNamed in SEC Form D filings
- Joseph NgExecutive Officer, DirectorNamed in SEC Form D filings
- Peggy SammonDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- APHIOS CORPORATIONSimilar federal contract value in Biotech · $723K in contracts
- PREDICTIVE BIOLOGYSimilar federal contract value in Biotech · $654K in contracts
- Perfinity Biosciences, Inc.Similar federal contract value in Biotech · $649K in contracts
- NEUCYTE INCSimilar federal contract value in Biotech · $602K in contracts
- TEICHOS LABORATORIES, LLCSimilar federal contract value in Biotech · $600K in contracts
- Proteovista LLCSimilar federal contract value in Biotech · $600K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .